IGF2BP2 was also positively correlated with key immune checkpoint molecules (PD‐L1, IDO1) and immunosuppressive cytokines (TGFB1) in TCGA‐BLCA (Figure 4I), suggesting its involvement in immune evasion. This evidence concerns the gene IGF2BP2 and bladder transitional cell carcinoma.